The Technology Behind Ingestible Insulin

Oct. 22 (Bloomberg) -- Oramed CEO Nadav Kidron discusses the technology behind ingestible insulin on Bloomberg Television's "Money Moves." (Source: Bloomberg)
Boomerang Employees: Companies Welcome Back Workers
21:37 - A new poll of human resources professionals finds that 76 percent would be willing to rehire former employees, representing a shift in the employee, employer relationship. Bloomberg's Betty Liu and Mark Crumpton report on "Bloomberg Markets." (Source: Bloomberg)
  • Stocks Revisit Session Lows, Oil Slumps, Gold Rises
  • Pope Francis to Expand Forgiveness on Abortion
  • Oil Pares Three-Day Rally, What's Next?